NH1 News Debates


Oct 13, 2014 12:41 PM

Canadian Ebola vaccine to begin testing

The Associated Press

TORONTO (AP) An experimental Canadian-made Ebola vaccine that has shown promise in tests on primates is beginning clinical trials on humans in the U.S.

The vaccine will be tested on healthy individuals Monday to see how well it works, whether there are side effects and what the proper dosage is, Health Minister Rona Ambrose said.

"The Canadian vaccine provides great hope and promise because it has shown to be 100 percent effective in preventing the spread of the Ebola virus when tested on animals," she said.

Studies in primates have shown this vaccine works both to prevent infection when given before exposure, and to increase survival chances when given quickly after exposure.

A small U.S. company called NewLink Genetics holds the license for the vaccine and the trials are set to begin in a lab in Maryland. Ambrose said the results are expected in December.

NewLink said earlier this month that at least five clinical trials involving the vaccine, known as VSV-EBOV, would soon be underway in the United States, Germany, Switzerland and in an unnamed African country that is not battling Ebola.


--  Dealing with the Disease of Addiction? Click here for help --

More from NH1.com

NH1 News Debates
NH1 News Replay

NH1 on Twitter

NH1 SkyView Cameras

NH1 on Facebook

Check out NH1 News Rail Polls on LockerDome on LockerDome